2025年4月18日 周五
Home > Archive>Volume 28, Issue 12, 2020 >1048-1053
PDF HTML XML Export Cite reminder
Effects of high-dose iodixanol on renal function in patients with diabetes undergoing percutaneous coronary intervention
CSTR:
[cstr]
Author:
Affiliation:

1.Department of Cardiology, the Second Affiliated Hospital of Army Medical University, PLA, Chongqing 400037, China;2.The 5th People’s Hospital of Chongqing, Chongqing 400062, China;3.The Fuling Central Hospital of Chongqing, Chongqing 408000, China;4.The 9th People’s Hospital of Chongqing, Chongqing 400700, China)

Clc Number:

R5

  • Article
    • | |
  • Metrics
    • |
  • Reference
    • |
  • Related
    • |
  • Cited by
    • | |
  • Comments
    Abstract:

    Aim To evaluate the effects of high-dose (＞300 mL) iodixanol on renal function of diabetic patients within 72 hours after percutaneous coronary intervention (PCI) . Methods From October 2015 to December 7,7 patients who received high-dose (＞300 mL) iodixanol during PCI in four centers were selected. Finally, 204 cases were enrolled in this study. The incidence of contrast-induced acute kidney injury (CI-AKI) was evaluated. ResultsThe incidence of CI-AKI was 3.9% (8/204). In patients administered 300～500 mL and ＞500 mL iodixanol, the incidence of CI-AKI was 4.3% (7/161) and 2.3% (1/43), respectively. In the subgroup with pre-PCI estimated glomerular filtration rate (eGFR)＜60 mL/(min·1.73 m2), the incidence of CI-AKI was 6.9%(2/29). Multivariate Logistic regression analysis showed independent risk factors for CI-AKI were chronic renal failure, anemia, emergency PCI, and high Mehran score, but not contrast volume. Conclusion The administration of high-dose (＞300 mL) iodixanol in patients with diabetes undergoing PCI does not result in high incidences of post-PCI CI-AKI.

    Reference
    Related
    Cited by
Get Citation

ZHAO Ning, CHEN Zaiyan, WANG Zhe, XU Qiang, ZHOU Yinpin, XU Zhonglin, SONG Yaoming, JIN Jun, HUANG Lan, ZHAO Xiaohui. Effects of high-dose iodixanol on renal function in patients with diabetes undergoing percutaneous coronary intervention[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2020,28(12):1048-1053.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 01,2020
  • Revised:February 19,2020
  • Online: December 14,2020
Article QR Code

You are the 32748 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025